Clinical Trials Logo
  1. Home
  2. Fever
  3. NCT05971901
  4. Details
NCT05971901 Clinical Trial

A Combinatorial Biomarker for Infection Diagnosis in Children

Fever Clinical Trial

— CROCODILE-I  

Official title:
A Combinatorial Biomarker for Infection Diagnosis in Children

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05971901
Other study ID # 233/22
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 24, 2023
Est. completion date November 2024

Study information
Verified date August 2023
Source Universität des Saarlandes
Contact Cihan Papan, MD
Phone +4968411623900
Email cihan.papan@uni-saarland.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement. Secondary objectives: - Qualitative evaluation of indication as well as adherence to the test result. - Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).

Recruitment information / eligibility
Status Recruiting
Enrollment 770
Est. completion date November 2024
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender All
Age group 5 Months and older
Eligibility Inclusion Criteria: - Suspicion of acute bacterial or viral infection - Requirement of at least one BV test during medical presentation Exclusion Criteria: - lack of informed consent

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• BV
The use of the BV test, ordered at the discretion of the treating physician

Locations
Country Name City State
Germany Sana Kliniken Berlin
Germany Universitätsklinikum Bonn Bonn
Germany Saarland University Homburg
Germany Universitätsklinikum Würzburg Würzburg

Sponsors (1)
Lead Sponsor Collaborator
Universität des Saarlandes

Country where clinical trial is conducted

Germany, 

Outcome
Type Measure Description Time frame Safety issue
Primary Antibiotics Number of participants treated with antibiotics up to 30 days
Secondary Antibiotic duration Length of antibiotic treatment per participant up to 30 days
Secondary Hospitalization Number of participants admitted to the hospital up to 30 days
Secondary Complications Rate of complications per participant up to 30 days
Secondary Tests Rate of ancillary tests per participant up to 30 days
See also
  Status Clinical Trial Phase
Completed NCT05525494 - Patient Portal Flu Vaccine Reminders (5) N/A
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Terminated NCT04583280 - A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV) Phase 3
Completed NCT03321968 - Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults Phase 3
Active, not recruiting NCT03251196 - TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
Completed NCT02561871 - A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers Phase 1
Terminated NCT02032056 - Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period N/A
Completed NCT01911143 - A Retrospective, Blinded Validation of a Host-response Based Diagnostics N/A
Completed NCT01419262 - DO IT Trial: Vitamin D Outcomes and Interventions In Toddlers Phase 3
Terminated NCT01432080 - Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant Phase 2
Completed NCT00984945 - Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults Phase 1
Completed NCT00127686 - Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Phase 1
Active, not recruiting NCT01107223 - Long Term Effect of General Practitioner Education on Antibiotic Prescribing N/A
Completed NCT03739112 - Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly Phase 3
Completed NCT04144491 - Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda N/A
Completed NCT05318235 - Virus Interactions in the Respiratory Tract; a Cohort Study With Children
Active, not recruiting NCT04170348 - Daily Vitamin D for Sickle-cell Respiratory Complications Phase 2
Completed NCT04525040 - ProbioKid as Prevention Among Kids With Frequent URTI N/A
Completed NCT05535777 - Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS) N/A
Not yet recruiting NCT05914324 - Outpatient Pediatric Pulse Oximeters in Africa N/A